Lung Carcinoma clinical trials

Explore recruiting lung carcinoma clinical trials.

Recruiting lung carcinoma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Lung Carcinoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Phase I trial of CArbonic Anhydrase Inhibition in combination with radiochemotherapy or radioimmunotherapy in small cell lung carcinoma (ICAR)

France

Human Pharmacology (Phase I)- Other EU CTIS Study details

Prospective feasibility pilot study evaluating the value of [68Ga]Ga-PENTIXAFOR PET-CT in patients with locally advanced or metastatic Small Cell Lung Cancer (SCLC) at diagnosis and disease progression (PASSIFLORE)

France

Human Pharmacology (Phase I)- Other EU CTIS Study details

Dose tapering and Early Discontinuation to InCreAse cosT-effictIveness Of immunotherapy for Non-small cell lung carcinoma trial number 1 (NVALT-30 - Dedication-1)

Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

A study to test different doses of obrixtamig (BI 764532) combined with ezabenlimab in patients with Small Cell Lung Carcinoma and other neuroendocrine neoplasms expressing DLL3

Belgium, France, Germany

Human Pharmacology (Phase I)- Other EU CTIS Study details

Study Investigating Tucatinib and Osimertinib Pharmacokinetics in Primary and Metastatic Brain Tumors: the STICK trial

Netherlands

Human Pharmacology (Phase I)- Other EU CTIS Study details

DAREON™-8: A study to test how well different doses of BI 764532 in addition to standard of care are tolerated by people with advanced small cell lung cancer

Poland, Belgium, France, Germany, Spain

Human Pharmacology (Phase I)- Other EU CTIS Study details

Lung Carcinoma trials by city

Lung Carcinoma in Toronto Lung Carcinoma in Vancouver Lung Carcinoma in Montreal Lung Carcinoma in Calgary Lung Carcinoma in Edmonton Lung Carcinoma in Ottawa Lung Carcinoma in Winnipeg Lung Carcinoma in Quebec City Lung Carcinoma in Hamilton Lung Carcinoma in Kitchener Lung Carcinoma in London Lung Carcinoma in Halifax Lung Carcinoma in New York Lung Carcinoma in Los Angeles Lung Carcinoma in Chicago Lung Carcinoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease